Therapeutic Targeting of Fibroblast Growth Factor Receptors in Gastric Cancer

Chemotherapy has become the global standard treatment for patients with metastatic or unresectable gastric cancer (GC), although outcomes remain unfavorable. Many molecular-targeted therapies inhibiting signaling pathways of various tyrosine kinase receptors have been developed, and monoclonal antib...

Descripción completa

Detalles Bibliográficos
Autores principales: Inokuchi, Mikito, Fujimori, Yoshitaka, Otsuki, Sho, Sato, Yuya, Nakagawa, Masatoshi, Kojima, Kazuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427097/
https://www.ncbi.nlm.nih.gov/pubmed/26000013
http://dx.doi.org/10.1155/2015/796380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427097/
https://www.ncbi.nlm.nih.gov/pubmed/26000013
http://dx.doi.org/10.1155/2015/796380

Ejemplares similares